Terms: = Prostate cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
11 results:
1. Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.
Zuckerman A; Crumb J; Kandah HM; Platt T; Duckworth D; Lo K; Mitchell D; Diamantides E; Streck CM; DeClercq J; Choi L; Patel R
J Manag Care Spec Pharm; 2023 Jul; 29(7):740-748. PubMed ID: 37404071
[No Abstract] [Full Text] [Related]
2. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With cancer.
Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
[TBL] [Abstract] [Full Text] [Related]
3. Occurrence of major anti-retinal autoantibodies associated with paraneoplastic autoimmune retinopathy.
Adamus G; Champaigne R; Yang S
Clin Immunol; 2020 Jan; 210():108317. PubMed ID: 31770612
[TBL] [Abstract] [Full Text] [Related]
4. [RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate French ccAFU guidelines – Update 2018–2020: prostate cancer].
Rozet F; Hennequin C; Beauval JB; Beuzeboc P; Cormier L; Fromont-Hankard G; Mongiat-Artus P; Ploussard G; Mathieu R; Brureau L; Ouzzane A; Azria D; Brenot-Rossi I; Cancel-Tassin G; Cussenot O; Rebillard X; Lebret T; Soulié M; Penna RR; Méjean A
Prog Urol; 2018 Nov; 28(12S):S79-S130. PubMed ID: 30392712
[TBL] [Abstract] [Full Text] [Related]
5. cancer-associated retinopathy preceding the diagnosis of cancer.
Hoogewoud F; Butori P; Blanche P; Brézin AP
BMC Ophthalmol; 2018 Nov; 18(1):285. PubMed ID: 30390655
[TBL] [Abstract] [Full Text] [Related]
6. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy.
Adamus G
Autoimmun Rev; 2009 Mar; 8(5):410-4. PubMed ID: 19168157
[TBL] [Abstract] [Full Text] [Related]
7. Socioeconomic disparities in psychosocial wellbeing in cancer patients.
Simon AE; Wardle J
Eur J Cancer; 2008 Mar; 44(4):572-8. PubMed ID: 18221866
[TBL] [Abstract] [Full Text] [Related]
8. Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation.
Muñoz E; Gómez F; Paz JI; Casado I; Silva JM; Corcuera MT; Alonso MJ
Eur J Histochem; 2003; 47(2):123-8. PubMed ID: 12777207
[TBL] [Abstract] [Full Text] [Related]
9. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy.
Peek R; Dijkstra BG; Meek B; Kuijpers RW
Clin Exp Immunol; 2002 Jun; 128(3):498-503. PubMed ID: 12067305
[TBL] [Abstract] [Full Text] [Related]
10. Complications after radical retropubic prostatectomy in the medicare population.
Benoit RM; Naslund MJ; Cohen JK
Urology; 2000 Jul; 56(1):116-20. PubMed ID: 10869638
[TBL] [Abstract] [Full Text] [Related]
11. [Laparoscopic lymphadenectomy for lymphatic staging in prostatic cancer: preliminary experience].
Rioja Sanz C; Mínguez Pemán JM; Blas Marín M; Martínez Bengoechea J; Rioja Sanz LA
Actas Urol Esp; 1991; 15(6):515-7. PubMed ID: 1838894
[TBL] [Abstract] [Full Text] [Related]
